Antitumor 2-(Aminocarbonyl)-1,2-bis(methylsulfonyl)-1-(2-chloroethyl)- hydrazines-Reference-Cited by-同舟云学术

Antitumor 2-(Aminocarbonyl)-1,2-bis(methylsulfonyl)-1-(2-chloroethyl)- hydrazines

Published:1996-01-01 Issue:3 Volume:39 Page:796-801
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Shyam Krishnamurthy¹,Penketh Philip G.¹,Loomis Regina H.¹,Rose William C.¹,Sartorelli Alan C.¹

Affiliation:

1. Department of Pharmacology and Experimental Therapeutics Program, Cancer Center, Yale University School of Medicine, New Haven, Connecticut 06520, and Department of Experimental Therapeutics, Pharmaceutical Research Institute, Bristol-Myers Squibb Co., Princeton, New Jersey 08543

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm9505021

Reference32 articles.

1. A comparative study of a bcnu containing 4-drug program versus mopp versus 3-drug combinations in advanced Hodgkin's disease.A cooperative study by the cancer and leukemia group B

2. 2-Halo derivatives of 3'-acetamido-3'-deoxyadenosine

3. Reactions of 1,3-bis(2-chloroethyl)-1-nitrosourea and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in aqueous solution

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Potential Development Sulfonylhydrazines for the Treatment of Alzheimer’s Disease;Biointerface Research in Applied Chemistry;2022-01-18

2. Synthetic DNA‐Targeted Chemotherapeutic Agents And Related Tumor‐Activated Prodrugs;Burger's Medicinal Chemistry and Drug Discovery;2021-04-26

3. Design Strategy for the EPR Tumor-Targeting of 1,2-Bis(sulfonyl)-1-alkylhydrazines;Molecules;2021-01-06

4. Development and Validation of LC–MS-MS Assay for the Determination of the Emerging Alkylating Agent Laromustine and Its Active Metabolite in Human Plasma;Journal of Chromatographic Science;2018-11-03

5. pH-dependent general base catalyzed activation rather than isocyanate liberation may explain the superior anticancer efficacy of laromustine compared to related 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)hydrazine prodrugs;Chemical Biology & Drug Design;2017-07-17